HLS Therapeutics Inc. (TSX:HLS)
Canada
· Delayed Price · Currency is CAD 4.650
+0.010 (0.22%)
Apr 28, 2026, 4:00 PM EST
HLS Therapeutics Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 145 | 151 | 125 | 127 | 318 | 487 | Upgrade
|
| Market Cap Growth | 13.50% | 20.64% | -1.37% | -60.20% | -34.60% | -14.81% | Upgrade
|
| Enterprise Value | 198 | 211 | 194 | 220 | 426 | 586 | Upgrade
|
| Last Close Price | 4.65 | 4.82 | 3.93 | 3.95 | 9.69 | 14.56 | Upgrade
|
| PS Ratio | 1.91 | 1.98 | 1.53 | 1.52 | 3.83 | 6.41 | Upgrade
|
| PB Ratio | 1.72 | 1.78 | 1.22 | 0.98 | 1.88 | 2.39 | Upgrade
|
| P/FCF Ratio | 6.27 | 6.50 | 10.87 | 6.09 | 13.92 | 23.48 | Upgrade
|
| P/OCF Ratio | 6.19 | 6.42 | 10.85 | 6.08 | 13.88 | 23.41 | Upgrade
|
| EV/Sales Ratio | 2.60 | 2.77 | 2.38 | 2.64 | 5.12 | 7.71 | Upgrade
|
| EV/EBITDA Ratio | 8.14 | 8.95 | 9.26 | 7.74 | 15.14 | 19.78 | Upgrade
|
| EV/FCF Ratio | 8.52 | 9.10 | 16.88 | 10.57 | 18.63 | 28.26 | Upgrade
|
| Debt / Equity Ratio | 0.81 | 0.81 | 0.93 | 0.90 | 0.78 | 0.61 | Upgrade
|
| Debt / EBITDA Ratio | 2.81 | 2.81 | 4.42 | 4.06 | 4.66 | 4.07 | Upgrade
|
| Debt / FCF Ratio | 2.94 | 2.94 | 8.32 | 5.56 | 5.76 | 5.96 | Upgrade
|
| Net Debt / Equity Ratio | 0.62 | 0.62 | 0.69 | 0.67 | 0.61 | 0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.22 | 2.22 | 3.37 | 3.05 | 3.68 | 3.26 | Upgrade
|
| Net Debt / FCF Ratio | 2.25 | 2.25 | 6.13 | 4.17 | 4.54 | 4.66 | Upgrade
|
| Asset Turnover | 0.37 | 0.37 | 0.31 | 0.28 | 0.24 | 0.21 | Upgrade
|
| Inventory Turnover | 1.84 | 1.84 | 1.58 | 1.43 | 1.20 | 0.99 | Upgrade
|
| Quick Ratio | 0.75 | 0.75 | 1.11 | 1.22 | 1.02 | 1.18 | Upgrade
|
| Current Ratio | 1.11 | 1.11 | 1.57 | 1.65 | 1.42 | 1.58 | Upgrade
|
| Return on Equity (ROE) | -18.69% | -18.69% | -23.25% | -24.69% | -16.50% | -7.95% | Upgrade
|
| Return on Assets (ROA) | -1.73% | -1.73% | -2.60% | -2.87% | -3.26% | -1.35% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.70% | -3.70% | -5.60% | -5.70% | -6.40% | -2.50% | Upgrade
|
| Earnings Yield | -11.72% | -11.31% | -22.63% | -28.70% | -10.03% | -3.41% | Upgrade
|
| FCF Yield | 15.96% | 15.39% | 9.20% | 16.42% | 7.18% | 4.26% | Upgrade
|
| Dividend Yield | - | - | - | 2.53% | 2.06% | 1.37% | Upgrade
|
| Buyback Yield / Dilution | 0.98% | 0.98% | 1.31% | 0.52% | -0.77% | -1.48% | Upgrade
|
| Total Shareholder Return | 0.98% | 0.98% | 1.31% | 3.06% | 1.29% | -0.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.